In-Home Genetic Tests Represent Risk
By Jesse Reynolds,
Newsday
| 10. 22. 2007
Residents of Long Island and elsewhere in the Northeast will soon see television ads recommending they "Be ready against cancer." One might assume these to be public service announcements calling for more exercise or diets rich in antioxidants. Instead, the ads will promote a test for genes related to breast cancer.
Although this will be the first major direct-to-consumer campaign promoting genetic testing, the manufacturer of the test will not be mentioned. Instead, small text at the bottom of the screens will let viewers know the ad is a "service" of Myriad Genetics, which holds patents on the tested genes.
Myriad's test is likely to be the tip of the iceberg, and what it suggests for the future is quite alarming. We'll soon see more advertising campaigns that, like those of drugs, prey on our insecurities and fears. And unlike Myriad's test, which must be ordered through your doctor, an increasing number of these will be available over the counter and performed in the privacy - and isolation - of your own home.
This trend highlights three troubling aspects of...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...